Tech Company Financing Transactions
TetraGenetics Funding Round
On 5/3/2017, TetraGenetics landed funding from JDRF T1D Fund.
Transaction Overview
Company Name
Announced On
5/3/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
91 Mystic St.
Arlington, MA 02474
USA
Arlington, MA 02474
USA
Phone
Website
Email Address
Overview
TetraGenetics is an entrepreneurial biotech company focused on the discovery of novel therapeutics for autoimmune disease and pain. We are the world leader in recombinant human ion channel protein production using our proprietary TetraExpress® system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Kahn
Chief Financial Officer
Kevin O'Brien
Chief Scientific Officer
Theodore Clark
VP - R & D
Paul Colussi
Browse more venture capital transactions:
Prev: 5/3/2017: Bitfusion.io venture capital transaction
Next: 5/3/2017: Wavedash venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs